MATTY MATHIVANNAN, MD
Internal Medicine Physician in WASHINGTON, District of Columbia. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.
What the federal data shows
MATTY MATHIVANNAN, MD reported a CMS MIPS final score of 87.8261/100 — above the 83.1 national average — and filed 1,560 Medicare Part D claims in 2023.
- 87.8261/100
- MIPS score · +5 vs avg
- 2K
- Part D claims, 2023
- 80%
- generic prescribing
- Likely
- board-certified (heuristic)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.
MATTY MATHIVANNAN, MD's MIPS score vs every scored U.S. clinician
CMS Merit-based Incentive Payment System (MIPS) final score, 2023 — the federal quality measure
88 Top 46% higher than 54% of 477,587 scored providers
Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source CMS Merit-based Incentive Payment System (MIPS) · 2023
MATTY MATHIVANNAN, MD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 1 hospital affiliation — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about MATTY MATHIVANNAN, MD?
High performer (top quartile)Primary specialty
Medicare Part D claims
MIPS final score
Specialty distribution in District of Columbia
How Internal Medicine Physician compares to other specialties among District of Columbia providers
Internal Medicine Physician share within District of Columbia
Internal Medicine Physician is one of the more visible NUCC categories in District of Columbia
Each bar reflects the share of in-state providers whose primary NUCC taxonomy matches the specialty. Long tail of ~690 NUCC codes folded into "Other" to keep the comparison legible.
Medicare quality performance — MIPS
MATTY MATHIVANNAN, MD's 2023 MIPS final score plotted against the Internal Medicine Physician national average
- MIPS Final Score
- 87.8261/100
- vs 83.1 national avg · 2023 performance year
MIPS final score (Internal Medicine Physician) — 87.8261/100 vs national avg 83.1
Quality benchmarks
- National MIPS avg 2023 reporting year
- Quality dim CMS Quality category
- Cost dim CMS Cost category
- Specialty volume Internal Medicine Physician US NPIs
87.8261/100 MIPS final score — 4.7 pts above the 83.1 national average
Quality, Cost, Promoting Interoperability, and Improvement Activities composite score for the 2023 performance year. Specialty: Internal Medicine Physician. Quality dim: 66.308. Cost dim: 66.488.
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
MATTY MATHIVANNAN, MD appears in the CMS NPPES registry as a Internal Medicine Physician provider holding MD credentials at 2141 K ST NW, WASHINGTON, DC, 20037, with a listed phone of (202) 293-8680. NPI 1679644736 was issued on 11/12/2006. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what MATHIVANNAN most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.
Medicare Part D records for calendar year 2023 show 1,560 prescription claims written by this provider, covering 268 Medicare beneficiaries and totaling roughly $427K in drug spend, split 20% brand-name and 80% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 87.8261/100 for the 2023 performance year (Quality 66.308, Cost 66.488), compared with the national average of 83.1.
Internal Medicine Physician is a high-volume specialty nationwide, with 172,858 enrolled providers across 56 states and an average of 2,716 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1679644736 |
|---|---|
| Specialty | Internal Medicine Physician |
| Credentials | MD |
| Gender | Male |
| NPI Issued | 11/12/2006 |
Verify this provider's license
PlainDoctor pulls this profile from the CMS NPPES public registry. Confirm MATTY MATHIVANNAN, MD's current license status, disciplinary history, and board certifications with the D.C. Board of Medicine in District of Columbia before relying on this page for a clinical or care decision.
How we sourced this profile
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
Reporting: Group practice
Hospital and facility affiliations
Facilities where MATTY MATHIVANNAN, MD bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.
Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).
Brand vs generic prescribing mix · Typical
20% brand-name claims vs 80% generic, on 1,560 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
Prescribing Breakdown
- 30-Day Fills
- 3,294
- Total Day Supply
- 94,583
- Brand vs Generic
- 20% brand / 80% generic
- Brand Drug Cost
- $404K
- Generic Drug Cost
- $22K
- Antibiotic Claims
- 18
Patient Demographics
- Average Patient Age
- 69.7 years
- Avg HCC Risk Score
- 1.19
- Gender Split
- 47% female / 53% male
- Age Distribution
- <65: 39, 65-74: 167, 75-84: 49, 85+: 13
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What MATTY MATHIVANNAN, MD prescribes most
Top Medicare Part D drugs by claim count, 2023
- Atorvastatin Calcium
Atorvastatin Calcium
166 claims
- Amlodipine Besylate
Amlodipine Besylate
104 claims
- Metformin Hcl
Metformin Hcl
72 claims
- Lisinopril
Lisinopril
69 claims
- Losartan Potassium 65
Losartan Potassium
65 claims
- Gabapentin 52
Gabapentin
52 claims
- Hydrochlorothiazide 48
Hydrochlorothiazide
48 claims
- Shingrix 46
Shingrix
46 claims
| Drug | Claims |
|---|---|
| Atorvastatin Calcium | 166 |
| Amlodipine Besylate | 104 |
| Metformin Hcl | 72 |
| Lisinopril | 69 |
| Losartan Potassium | 65 |
| Gabapentin | 52 |
| Hydrochlorothiazide | 48 |
| Shingrix Varicella-Zoster Ge/As01b/Pf | 46 |
| Metformin Hcl Er Metformin Hcl | 40 |
| Glipizide | 33 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Internal Medicine Physician Overview
How MATTY MATHIVANNAN, MD fits within the Internal Medicine Physician landscape nationally.
MATTY MATHIVANNAN, MD's 1,560 claims are below the specialty average of 2,716.
Nearby Internal Medicine Physician Providers in District of Columbia
Other clinicians with the same primary specialty enrolled in District of Columbia, drawn from the same CMS NPPES roster as MATHIVANNAN.
Compare Internal Medicine Physician nationally: see state-by-state distribution →
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
Explore District of Columbia
Frequently Asked Questions
What is MATTY MATHIVANNAN, MD's specialty? ▼
How much does MATTY MATHIVANNAN, MD prescribe under Medicare Part D? ▼
What is MATTY MATHIVANNAN, MD's Medicare quality score? ▼
Where is MATTY MATHIVANNAN, MD located? ▼
What is MATTY MATHIVANNAN, MD's NPI number? ▼
Does MATTY MATHIVANNAN, MD prescribe more brand-name or generic drugs? ▼
How many Internal Medicine Physician providers are there in the US? ▼
What drugs does MATTY MATHIVANNAN, MD prescribe most often? ▼
Does MATTY MATHIVANNAN, MD accept Medicare? ▼
How can I verify MATTY MATHIVANNAN, MD's credentials? ▼
Data Sources
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology